Dashboard
1
Poor Management Efficiency with a low ROCE of 5.04%
- The company has been able to generate a Return on Capital Employed (avg) of 5.04% signifying low profitability per unit of total capital (equity and debt)
2
Poor long term growth as Net Sales has grown by an annual rate of -2.46% and Operating profit at -0.22% over the last 5 years
3
Positive results in Sep 25
4
With ROE of 6.35%, it has a fair valuation with a 3.04 Price to Book Value
5
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
CNY 906 Million (Small Cap)
48.00
NA
1.91%
-0.46
7.00%
0.89
Revenue and Profits:
Net Sales:
284 Million
(Quarterly Results - Mar 2026)
Net Profit:
32 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.27%
0%
-4.27%
6 Months
-3.28%
0%
-3.28%
1 Year
-4.78%
0%
-4.78%
2 Years
45.03%
0%
45.03%
3 Years
53.2%
0%
53.2%
4 Years
53.7%
0%
53.7%
5 Years
-11.85%
0%
-11.85%
Guangdong Transtek Medical Electronics Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
-2.46%
EBIT Growth (5y)
-0.22%
EBIT to Interest (avg)
14.78
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.46
Sales to Capital Employed (avg)
0.73
Tax Ratio
2.70%
Dividend Payout Ratio
98.35%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
5.04%
ROE (avg)
3.73%
Valuation key factors
Factor
Value
P/E Ratio
48
Industry P/E
Price to Book Value
3.04
EV to EBIT
49.97
EV to EBITDA
34.78
EV to Capital Employed
4.63
EV to Sales
2.63
PEG Ratio
2.63
Dividend Yield
0.56%
ROCE (Latest)
9.26%
ROE (Latest)
6.35%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
283.70
229.10
23.83%
Operating Profit (PBDIT) excl Other Income
35.30
20.70
70.53%
Interest
0.00
0.00
Exceptional Items
1.20
0.60
100.00%
Consolidate Net Profit
31.90
15.50
105.81%
Operating Profit Margin (Excl OI)
124.30%
60.20%
6.41%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 23.83% vs -2.84% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 105.81% vs -34.04% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
980.10
979.00
0.11%
Operating Profit (PBDIT) excl Other Income
124.20
81.40
52.58%
Interest
3.80
6.90
-44.93%
Exceptional Items
-16.60
-12.50
-32.80%
Consolidate Net Profit
80.30
58.20
37.97%
Operating Profit Margin (Excl OI)
96.40%
52.40%
4.40%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 0.11% vs 11.31% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 37.97% vs 86.54% in Dec 2024
About Guangdong Transtek Medical Electronics Co., Ltd. 
Guangdong Transtek Medical Electronics Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






